ACRS Q1 2025 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1M-39.3% YoY

Gross Profit

$949,00065.2% margin

Operating Income

-$18M-1242.9% margin

Net Income

-$15M-1036.8% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-84.2%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$198M

Total Liabilities

$54M

Stockholders' Equity

$144M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-39.3%
Gross Profit	$949,000	$558,000	+70.1%
Operating Income	-$18M	-$19M	+4.5%
Net Income	-$15M	-$17M	+11.0%

Revenue Segments

License and Service

$1M69%

Contract research

$445,00031%